Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
48.5M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
31M
-
Shares change
-
+6.44M
-
Total reported value, excl. options
-
$607M
-
Value change
-
+$126M
-
Number of buys
-
45
-
Number of sells
-
-12
-
Price
-
$19.39
Significant Holders of Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (ORKA) as of Q4 2024
71 filings reported holding ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q4 2024.
Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (ORKA) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31M shares
of 48.5M outstanding shares and own 64.02% of the company stock.
Largest 10 shareholders include FMR LLC (5.51M shares), Fairmount Funds Management LLC (3.37M shares), VR Adviser, LLC (3.29M shares), RTW INVESTMENTS, LP (1.95M shares), VANGUARD GROUP INC (1.61M shares), COMMODORE CAPITAL LP (1.42M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.33M shares), BRAIDWELL LP (1.15M shares), JANUS HENDERSON GROUP PLC (849K shares), and PERCEPTIVE ADVISORS LLC (846K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.